Trupanion (TRUP) Expected to Release Quarterly Earnings on Wednesday

Trupanion (NASDAQ:TRUP) is expected to issue its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Trupanion to announce earnings of $0.11 per share and revenue of $389.7170 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.04. The firm had revenue of $384.05 million during the quarter, compared to the consensus estimate of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.03) EPS. On average, analysts expect Trupanion to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Trupanion Stock Performance

NASDAQ TRUP traded up $0.12 during trading on Wednesday, hitting $25.62. The company’s stock had a trading volume of 47,453 shares, compared to its average volume of 413,156. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25. The firm has a 50 day moving average price of $24.14 and a 200 day moving average price of $26.64. The firm has a market cap of $1.12 billion, a P/E ratio of 43.36 and a beta of 1.39. Trupanion has a 52 week low of $21.16 and a 52 week high of $57.00.

Analyst Ratings Changes

TRUP has been the topic of a number of research reports. Atlantic Securities set a $42.00 target price on shares of Trupanion in a research report on Wednesday, July 15th. Zacks Research raised shares of Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Cantor Fitzgerald reduced their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Stifel Nicolaus set a $28.00 price target on shares of Trupanion in a research report on Friday, June 26th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Trupanion has a consensus rating of “Moderate Buy” and a consensus price target of $41.60.

Insiders Place Their Bets

In other news, COO John R. Gallagher sold 3,603 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $21.69, for a total transaction of $78,149.07. Following the sale, the chief operating officer directly owned 33,065 shares in the company, valued at approximately $717,179.85. The trade was a 9.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Fawwad Qureshi sold 6,177 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total value of $137,005.86. Following the completion of the transaction, the chief financial officer directly owned 2,081 shares of the company’s stock, valued at approximately $46,156.58. This trade represents a 74.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 17,376 shares of company stock worth $383,642. 5.58% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Trupanion

Hedge funds have recently made changes to their positions in the business. Royal Bank of Canada lifted its holdings in shares of Trupanion by 60.6% during the 1st quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock worth $1,109,000 after acquiring an additional 11,233 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Trupanion by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock worth $731,000 after purchasing an additional 858 shares in the last quarter. Millennium Management LLC boosted its holdings in Trupanion by 73.5% during the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock valued at $9,987,000 after purchasing an additional 113,490 shares in the last quarter. Invesco Ltd. boosted its holdings in Trupanion by 35.1% during the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock valued at $10,392,000 after purchasing an additional 48,781 shares in the last quarter. Finally, Gabelli Funds LLC bought a new stake in shares of Trupanion in the 2nd quarter valued at approximately $249,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.